Effects of Oxidized Low-density Lipoprotein on Bone Marrow Stem Cell

氧化低密度脂蛋白对骨髓干细胞的影响

基本信息

  • 批准号:
    7890139
  • 负责人:
  • 金额:
    $ 38.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-06-01 至 2015-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Adult bone marrow multipotent progenitor cells (MAPCs) are one of well characterized bone marrow- derived stem cells. Our initial studies show that oxidized low-density lipoprotein (ox-LDL) significantly inhibits the proliferation of murine MAPCs and their endothelial differentiation in association with a selective and dramatic reduction of serine/threonine kinase Akt (Akt) phosphorylation. It is well known that the number and function of endothelial progenitor cells (EPCs) are markedly reduced in the patients with hyperlipidemia. The present study will test the hypothesis that ox-LDL reduces stem cell population within the bone marrow, and impairs their differentiation into EPCs due to interrupted Akt signaling. The specific aims are: 1). To evaluate the effect of ox-LDL on the population of stem cells within bone marrow and the underlying mechanisms; and 2). To investigate the role of ox-LDL in the differentiation of MAPCs into EPCs and the underlying mechanisms. Murine MAPCs will be isolated, cultured and quantitatively analyzed from both hyperlipidemic male LDL receptor knock out (LDLR-/-) mice (with atherogenic diet) and ox-LDL-infused wild-type (WT) normal C57BL/6 mice. The number of MAPCs within the bone marrow, Oct-4 expression, and their proliferation and differentiation into EPCs will be evaluated. To further test the hypothesis, bone marrow transplantation with eGFP- labeled MAPCs will be performed in LDLR(-/-) mice and ox-LDL-infused WT mice. The eGFP-positive EPCs will be isolated and quantitatively analyzed from the animals for EPC number and function. If the hypothesis is true, it is expected that the population and function of MAPCs within the bone marrow and EPCs in the bone marrow and peripheral blood will be significantly decreased in ox-LDL-infused animals and in hyperlipidemic LDLR(-/-) mice. It is also anticipated that Oct-4 expression, cell proliferation, and endothelial differentiation of the MAPCs isolated from the hyperlipidemic LDLR(-/-) mice and ox-LDL- infused WT mice will be significantly decreased along with a significant reduction in Akt phosphorylation in MAPCs. Conversely, the number and function of eGFP-positive MAPCs within the bone marrow and EPCs in the bone marrow and peripheral blood will increase significantly in the animals (both hyperlipidemic mice and ox-LDL-infused WT mice) that receive bone marrow transplantation with eGFP- positive MAPCs transfected with retroviral Akt1 vectors, and stably over-expressing active Akt. In addition, overexpression of active Akt will decrease atherosclerotic plaque formation in hyperlipidemic mice, and enhance vascular repair with reduced neointima formation in ox-LDL-infused mice. The data from this study will provide novel information on the mechanisms for the development of atherosclerosis in patients with hyperlipidemia, and help explore new approaches to preventing and treating cardiovascular diseases. PUBLIC HEALTH RELEVANCE: Endothelial progenitor cells (EPCs) originate from the bone marrow stem cells. These cells play a critical role in maintaining the structural and functional integrity of the endothelial monolayer in blood vessels. The number of EPCs is markedly reduced along with significantly decreased EPC function in hyperlipidemic patients. Oxidized low-density lipoprotein (ox-LDL) is a key element that is associated with cardiovascular diseases in hyperlipidemic patients. This study will investigate how ox-LDL disrupts the generation and function of EPCs in the bone marrow.
描述(申请人提供):成人骨髓多能祖细胞(MAPC)是一种特性良好的骨髓源性干细胞。我们的初步研究表明,氧化型低密度脂蛋白(OX-LDL)显著抑制小鼠MAPC的增殖及其内皮分化,并选择性地显著降低丝氨酸/苏氨酸激酶Akt(Akt)的磷酸化。众所周知,高脂血症患者内皮祖细胞的数量和功能明显降低。目前的研究将验证这一假说,即OX-LDL减少了骨髓中的干细胞数量,并由于Akt信号中断而损害了它们向内皮祖细胞的分化。具体目标是:1)。2)探讨氧化低密度脂蛋白对骨髓干细胞数量的影响及其机制;探讨氧化低密度脂蛋白(ox-LDL)在MAPC向EPC分化过程中的作用及其机制。从高脂血症性雄性低密度脂蛋白受体基因敲除(LDLR-/-)小鼠(用致动脉粥样硬化的饮食)和注入OX-低密度脂蛋白(WT)的野生型(WT)正常C57BL/6小鼠中分离、培养和定量分析小鼠MAPC。将评估骨髓中MAPC的数量、OCT-4的表达以及它们的增殖和分化为内皮祖细胞。为了进一步验证这一假设,将在LDLR(-/-)小鼠和注射ox-LDL的WT小鼠身上进行带有EGFP标记的MAPC的骨髓移植。将从动物中分离出EGFP阳性的EPC,并对EPC的数量和功能进行定量分析。如果这一假说是真的,那么在注射ox-LDL的动物和高脂血症LDLR(-/-)小鼠中,骨髓中的MAPC以及骨髓和外周血中的EPC的数量和功能将显著减少。还预计,从高脂血症LDLR(-/-)小鼠和ox-LDL注射的WT小鼠分离的MAPC的Oct-4表达、细胞增殖和内皮分化将显著降低,同时MAPC中Akt的磷酸化显著减少。相反,骨髓中EGFP阳性MAPC的数量和功能将显著增加,骨髓和外周血中的EPC将显著增加(无论是高脂血症小鼠还是OX-LDL注入的WT小鼠),接受骨髓移植的EGFP阳性MAPC的数量和功能将显著增加,并稳定过表达活性Akt。此外,活性Akt的过表达将减少高脂血症小鼠动脉粥样硬化斑块的形成,并通过减少ox-LDL注射的小鼠的新生内膜形成来促进血管修复。这项研究的数据将为高脂血症患者动脉粥样硬化的发生机制提供新的信息,并有助于探索预防和治疗心血管疾病的新方法。 公共卫生相关性:内皮祖细胞(EPC)来源于骨髓干细胞。这些细胞在维持血管内皮单分子层的结构和功能完整性方面起着关键作用。高脂血症患者EPC数量明显减少,EPC功能明显降低。氧化低密度脂蛋白(ox-LDL)是高脂血症患者发生心血管疾病的关键因素。本研究将探讨氧化低密度脂蛋白如何干扰骨髓中内皮祖细胞的生成和功能。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ZHENGUO LIU其他文献

ZHENGUO LIU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ZHENGUO LIU', 18)}}的其他基金

Fine particulate matter exposure and small cerebrovascular inflammation
细颗粒物暴露与小脑血管炎症
  • 批准号:
    10807363
  • 财政年份:
    2023
  • 资助金额:
    $ 38.13万
  • 项目类别:
Implantable real-time troponin biosensor for early diagnosis of silent cardiac injuries
植入式实时肌钙蛋白生物传感器用于早期诊断无症状心脏损伤
  • 批准号:
    10932735
  • 财政年份:
    2023
  • 资助金额:
    $ 38.13万
  • 项目类别:
Helicobacter pylori infection and endothelial dysfunction
幽门螺杆菌感染与内皮功能障碍
  • 批准号:
    9803355
  • 财政年份:
    2019
  • 资助金额:
    $ 38.13万
  • 项目类别:
Helicobacter pylori infection and endothelial dysfunction
幽门螺杆菌感染与内皮功能障碍
  • 批准号:
    10252889
  • 财政年份:
    2019
  • 资助金额:
    $ 38.13万
  • 项目类别:
Helicobacter pylori infection and endothelial dysfunction
幽门螺杆菌感染与内皮功能障碍
  • 批准号:
    10458021
  • 财政年份:
    2019
  • 资助金额:
    $ 38.13万
  • 项目类别:
Ambient fine particulate matter and bone marrow stem cells
环境细颗粒物和骨髓干细胞
  • 批准号:
    9767135
  • 财政年份:
    2016
  • 资助金额:
    $ 38.13万
  • 项目类别:
Ambient fine particulate matter and bone marrow stem cells
环境细颗粒物和骨髓干细胞
  • 批准号:
    9690411
  • 财政年份:
    2016
  • 资助金额:
    $ 38.13万
  • 项目类别:
Oxidized Low-density Lipoprotein Impairs Bone Marrow Stem Cell Survival
氧化低密度脂蛋白损害骨髓干细胞的存活
  • 批准号:
    9128038
  • 财政年份:
    2015
  • 资助金额:
    $ 38.13万
  • 项目类别:
Effects of Oxidized Low-density Lipoprotein on Bone Marrow Stem Cell
氧化低密度脂蛋白对骨髓干细胞的影响
  • 批准号:
    8274871
  • 财政年份:
    2010
  • 资助金额:
    $ 38.13万
  • 项目类别:
Effects of Oxidized Low-density Lipoprotein on Bone Marrow Stem Cell
氧化低密度脂蛋白对骨髓干细胞的影响
  • 批准号:
    8676877
  • 财政年份:
    2010
  • 资助金额:
    $ 38.13万
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 38.13万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 38.13万
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    $ 38.13万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    $ 38.13万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 38.13万
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    $ 38.13万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 38.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了